✦ LIBER ✦

First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule

✍ Scribed by Quoix, Elisabeth; Breton, Jean-Luc; Ducoloné, Alain; Mennecier, Bertrand; Depierre, Alain; Lemarié, Etienne; Moro-Sibilot, Denis; Germa, Caroline; Neidhardt, Anne-Catherine

Book ID: 119319077
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 155 KB
Volume: 47
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2004.08.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine plus docetaxel as first-line

Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB

A 4-week versus a 3-week schedule of gem

A 4-week versus a 3-week schedule of gemcitabine monotherapy for advanced pancreatic cancer: a randomized phase II study to evaluate toxicity and dose intensity

✍ Ken Hirao; Hirofumi Kawamoto; Ichiro Sakakihara; Yasuhiro Noma; Naoki Yamamoto; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 348 KB

A Prospective Study of Gemcitabine and C

A Prospective Study of Gemcitabine and Carboplatin as First-Line Therapy in Advanced Non-Small Cell Lung Cancer: Toxicity of a Three- Versus a Four-Week Schedule

✍ Bárbara Parente; Ana Barroso; Sara Conde; Tânia Guimarăes; Jorge Seada 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 594 KB

Gemcitabine monotherapy in elderly patie

Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer A multicenter phase II study

✍ Ricci, S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Phase II study of gemcitabine plus oxali

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer

✍ Cappuzzo, F; Novello, S; De Marinis, F; Franciosi, V; Maur, M; Ceribelli, A; Lor 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

Three-week schedule of irinotecan and ci

Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study

✍ Cardenal, F 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 120 KB